“CRISPR/Cas9-Mediated Reprogramming of Medicinal Plants for Enhanced Anti-Cancer Bioactive Compounds ‘Advances in Genome Editing for Plant-Derived Therapeutics’” (2025) Journal of Carcinogenesis, 24(3), pp. 350–356. doi:10.64149/J.Carcinog.24.3.350-356.